Bio-Reference Laboratories Company Profile (NASDAQ:BRLI)

Analyst Ratings

Consensus Ratings for Bio-Reference Laboratories (NASDAQ:BRLI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Bio-Reference Laboratories (NASDAQ:BRLI)
Show:
DateFirmActionRatingPrice TargetActions
12/18/2014William BlairReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2014Bank of America Corp.DowngradeUnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Bio-Reference Laboratories (NASDAQ:BRLI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/25/2015        
6/8/2015Q215$0.44$0.38$227.33 million$224.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/5/2015Q115$0.36$0.24$216.40 million$209.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/18/2014Q414$0.63$0.69$228.81 million$227.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/27/2014Q314$0.53$0.55$210.44 million$222.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/5/2014Q214$0.32$0.37$0.20 million$201.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2014Q114$0.15$0.11$175.52 million$181.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/19/2013Q4$0.55$0.40$188.96 million$192.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/29/2013Q3 2013$0.51$0.53$183.50 million$185.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/6/2013Q2 2013$0.41$0.41$176.04 million$176.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2013Q1 2013$0.28$0.31$165.44 million$161.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/6/20120.46$0.46$175.46 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/30/2012Q312$0.43$0.45$0.17 million$0.17 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/7/2012$0.32$0.33ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/1/2012$0.21$0.26ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/8/2011$0.35$0.37ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/25/2011$0.34$0.36ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/26/2011$0.24$0.26ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2011$0.17$0.28ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/16/2010$0.30$0.31$124.19 million$126.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bio-Reference Laboratories (NASDAQ:BRLI)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Bio-Reference Laboratories (NASDAQ:BRLI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Bio-Reference Laboratories (NASDAQ:BRLI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
9/13/2013Howard DubinettCOOSell20,000$29.40$588,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/27/2013Sam SingerCFOSell4,000$28.95$115,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2013Sam SingerCFOSell6,000$28.50$171,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Bio-Reference Laboratories (NASDAQ:BRLI)
DateHeadline
06/30/16 04:15 PMOpko Is a Buying Opportunity After FDA's Approval of Kidney Drug -
05/27/16 08:50 PMBio-Reference Laboratories, Inc. (NASDAQ:BRLI) Updated Price Targets - FTSE News - Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) Updated Price TargetsFTSE NewsBio-Reference Laboratories, Inc. has a 50 day moving average of 41.81 and a 200 day moving average of 36.97. It has a 52-week low of 26.32 and a 52-week high of 47.49. The share price of the company (NASDAQ:BRLI) was up +0.00%, with a high of 0.00 ...
05/22/16 11:51 PMNext Weeks Broker Price Targets For Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) - Share Trading News - Next Weeks Broker Price Targets For Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)Share Trading NewsBio-Reference Laboratories, Inc. has a 50 day moving average of 41.81 and a 200 day moving average of 36.97. It has a 52-week low of 26.32 and a 52-week high of 47.49. The share price of the company (NASDAQ:BRLI) was up +0.00%, with a high of 0.00 ...and more »
05/18/16 08:04 PMLatest Analyst Ratings For Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) - Share Trading News - Latest Analyst Ratings For Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)Share Trading NewsBio-Reference Laboratories, Inc. has a 50 day moving average of 41.81 and a 200 day moving average of 36.97. It has a 52-week low of 26.32 and a 52-week high of 47.49. The share price of the company (NASDAQ:BRLI) was up +0.00%, with a high of 0.00 ...
04/12/16 02:07 AMBio-Reference Laboratories, Inc. (NASDAQ:BRLI) Latest Broker Views - Risers & Fallers - Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) Latest Broker ViewsRisers & FallersA number of investment brokers have recently updated their price targets on shares of Bio-Reference Laboratories, Inc. (NASDAQ:BRLI). According to the latest broker reports outstanding on Monday 11th of April, 0 analysts have a rating of “strong buy”, ...and more »
04/08/16 11:28 PMBio-Reference Laboratories, Inc. (NASDAQ:BRLI) Updated Broker Price Targets - Share Trading News - Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Bio-Reference Laboratories, Inc. (NASDAQ:BRLI). The latest reports which are currently in issue on Friday 8th of April state 0 analysts have a rating of “strong buy”, 0 ...and more »
04/05/16 08:41 PMNew Analyst Ratings On Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) - Risers & Fallers - New Analyst Ratings On Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Bio-Reference Laboratories, Inc. (NASDAQ:BRLI). The latest broker reports which are currently outstanding on Tuesday 5th of April state 0 analysts have a rating of “strong ...and more »
03/31/16 08:28 PMBio-Reference Laboratories, Inc. (NASDAQ:BRLI) Updated Broker Ratings - Risers & Fallers - Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) Updated Broker RatingsRisers & FallersA number of investment brokers have recently updated their price targets on shares of Bio-Reference Laboratories, Inc. (NASDAQ:BRLI). According to the latest broker reports outstanding on Thursday 31st of March, 0 analysts have a rating of “strong buy ...and more »
03/22/16 07:17 PMNext Weeks Broker Price Targets For Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) - Risers & Fallers - Next Weeks Broker Price Targets For Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)Risers & FallersBio-Reference Laboratories, Inc. has a 50 day moving average of 41.81 and a 200 day moving average of 36.97. It has a 52-week low of 26.32 and a 52-week high of 47.49. The share price of the company (NASDAQ:BRLI) was up +0.00%, with a high of 0.00 ...and more »
03/18/16 03:19 PMHow Risky Is Opko Health Inc. Stock? -
03/17/16 09:55 PMRecent Broker Updates On Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) - Risers & Fallers - Recent Broker Updates On Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Bio-Reference Laboratories, Inc. (NASDAQ:BRLI). The latest broker reports which are currently outstanding on Thursday 17th of March state 0 analysts have a rating of ...
03/15/16 06:52 PMBio-Reference Laboratories, Inc. (NASDAQ:BRLI) New Analyst Ratings - Share Trading News - Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) New Analyst RatingsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Bio-Reference Laboratories, Inc. (NASDAQ:BRLI). The latest reports which are currently in issue on Tuesday 15th of March state 0 analysts have a rating of “strong buy”, ...
03/08/16 08:05 PMUpdated Price Targets On Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) - Risers & Fallers - Updated Price Targets On Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Bio-Reference Laboratories, Inc. (NASDAQ:BRLI). The latest broker reports which are currently outstanding on Monday 7th of March state 0 analysts have a rating of “strong ...
02/04/16 09:22 AMBio-Reference Laboratories, Inc. (NASDAQ:BRLI) Recent Analyst Updates - Risers & Fallers - Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) Recent Analyst UpdatesRisers & FallersA number of investment brokers have recently updated their price targets on shares of Bio-Reference Laboratories, Inc. (NASDAQ:BRLI). According to the latest broker reports outstanding on Wednesday 3rd February, 0 analysts have a rating of “strong buy ...
01/27/16 08:55 AMAnalyst Coverage Updates - Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) - Risers & Fallers - Analyst Coverage Updates - Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Bio-Reference Laboratories, Inc. (NASDAQ:BRLI). The latest broker reports which are currently outstanding on Wednesday 27th January state 0 analysts have a rating of ...and more »
12/05/15 08:03 AM3 Predictions for Opko Health Inc. in 2016 -
11/19/15 06:57 AMOpko Health Reports a Surprise Profit -- Were Investors Right to Cheer? -
11/06/15 10:34 AMOPKO Health Refinances Bio-Reference Laboratories Credit Facility - [at noodls] - November 6, 2015 MIAMI--(BUSINESS WIRE)-- OPKO Health, Inc. (NYSE:OPK) today announced today that it has successfully closed on a new five-year $175.0 million secured revolving credit facility with JPMorgan ...
09/28/15 09:44 AMOpko Health Has Crashed 55% In Three Months; Time To Buy? -
09/24/15 09:24 AMWhy Insiders Are Buying Opko Health, Inc. Stock -
08/25/15 12:04 PMOPKO HELATH, INC. Financials -
08/20/15 05:38 PMInnospec Set to Join the S&P SmallCap 600 - [PR Newswire] - NEW YORK, Aug. 20, 2015 /PRNewswire/ -- Innospec Inc. (NASD:IOSP) will replace Bio-Reference Laboratories Inc. (NASD:BRLI) in the S&P SmallCap 600 after the close of trading on Friday, August 21. OPKO ...
08/20/15 04:05 PMBIO REFERENCE LABORATORIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisit -
08/20/15 10:06 AMOPKO Completes Acquisition of Bio-Reference Laboratories - [at noodls] - MIAMI--(BUSINESS WIRE)-- OPKO Health, Inc. (NYSE: OPK) and Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) today announced the completion of the acquisition of Bio-Reference by OPKO. Shareholders of Bio-Reference ...
08/10/15 04:08 PMBIO REFERENCE LABORATORIES INC Files SEC form 8-K, Other Events -
07/23/15 07:59 AMOPKO's Prostate Cancer Hit -
07/05/15 12:05 AMOPKO and Bio-Reference Laboratories Announce Early Termination of the Waiting Period for Planned Acquisition - [at noodls] - MIAMI--(BUSINESS WIRE)-- OPKO Health, Inc. (NYSE:OPK) and Bio-Reference Laboratories, Inc. (NASDAQ:BRLI), today announced that early termination of the waiting period under the Hart-Scott-Rodino Antitrust ...
06/21/15 06:13 PMBarron's Recap: Airline Stocks Ready To Soar -
06/16/15 10:44 AMBRLI INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Bio-Reference Laboratories, Inc. Concerning the Sale of the Company to Opko Health Inc. - [Business Wire] - The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Bio-Reference Laboratories, Inc. in connection with the sale of the Company to Opko Health, Inc.

Social

About Bio-Reference Laboratories

Bio-Reference Laboratories logoBio-Reference Laboratories, Inc. is a clinical testing laboratory, which offers testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a range of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It is focused on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional health care. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology and other tissue analysis. It operates a clinical knowledge management service through its PSIMedica business unit. It also operates a Web-based connectivity portal solution for laboratories and physicians through its CareEvolve subsidiary. Its laboratory testing business consists of routine testing and esoteric testing.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Health Care Services
  • Exchange: NASDAQ
  • Symbol: BRLI
  • CUSIP: 09057G60
Key Metrics:
  • Previous Close: $34.61
  • 50 Day Moving Average: $41.81
  • 200 Day Moving Average: $36.97
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Current Year EPS Consensus Estimate: $1.98 EPS
  • Next Year EPS Consensus Estimate: $2.31 EPS
Additional Links:
Bio-Reference Laboratories (NASDAQ:BRLI) Chart for Thursday, July, 28, 2016